Pliant Therapeutics Inc

NASDAQ:PLRX 4:00:00 PM EDT

27.52

-0.13 (-0.47%)

5:04:12 PM EDT: $27.52 0.00 (0.00%)

Market Cap (Intraday)	1.62B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.32 Million
Adjusted EPS	-$0.67

See more estimates

10-Day MA	$28.31
50-Day MA	$29.57
200-Day MA	$21.17

See more pivots

Pliant Therapeutics Inc Stock, NASDAQ:PLRX

260 Littlefield Avenue, South San Francisco, California 94080

United States of America

Phone: +1.650.481.6770

Number of Employees: 124

http://www.pliantrx.com

Description

Pliant Therapeutics, Inc. engages in the discovery and development of therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-�?�?1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.